Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03615391 : Predictive Role and HuR Mechanisms of Regulation in the Brain Tumours
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria

- Grade I and II meningiomas (WHO)

- Diffuse grade II glioma (astrocytoma, oligodendroglioma)

- Grade III anaplastic gliomas (astrocytomas and anaplastic oligodendrogliomas)

- Grade IV glioblastoma
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03615391      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740